ABBVIE INC (ABBV)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ABBV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ABBV | Chairman of the Board and Chief Executive Officer | 55 | ["Chairman and Chief Executive Officer of AbbVie Inc.", "Chief Executive Officer starting in 2024", "President and Chief Operating Officer from July 2023 to June 2024", "Vice Chairman and President from June 2022 to July 2023", "Vice Chairman, Finance and Commercial Operations and Chief Financial Officer from June 2021 to June 2022", "Executive Vice President, Chief Financial Officer from 2019 to 2021", "Senior Vice President, Chief Financial Officer from 2018 to 2019", "Joined Abbott in 1993"] | ["Audit", "Compensation"] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Michael is AbbVie s Chairman and Chief Executive Officer, a position he has held since July 2025. Mr. Michael previously served as Chief Executive Officer starting in 2024 and President and Chief Operating Officer from July 2023 to June 2024, where he was responsible for global commercial operations, finance, corporate human resources, global operations, business development and corporate strategy for the company. He previously served as Vice Chairman and President from June 2022 to July 2023, as Vice Chairman, Finance and Commercial Operations and Chief Financial Officer from June 2021 to June 2022, as Executive Vice President, Chief Financial Officer from 2019 to 2021, and as Senior Vice President, Chief Financial Officer from 2018 to 2019. Mr. Michael first joined Abbott in 1993 and held numerous leadership positions across several different business units before joining AbbVie in 2013.